Clinical Trials Sponsored by Novastep

Total 8 results

Novastep

Recruiting

Correction of Hallux Valgus With the Nexis® PECA Bunion Implantable Osteosynthesis Medical Device (PECA)

Hallux Valgus

France
Novatek Pharmaceuticals

Recruiting

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. (BOSS-002)

COVID-19

United States
Novatek Pharmaceuticals

Completed

To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants (BOSS)

Covid19

United States
Novatex Medical
EVAMED

Active, not recruiting

Efficiency Clinical Study of NOVATEX MEDICAL Compression Garments in Patients With Ehlers-Danlos Syndrome (NOVASED)

Ehlers-Danlos Syndrome

France
University of Florida
Novatek

Not yet recruiting

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Hepatocellular Carcinoma
Boston Scientific Corporation
Novate Medical

Completed

The SENTRY Clinical Study (SENTRY)

Deep Vein Thrombosis | Pulmonary Embolism

United States, Chile, Belgium
Amr Mohamed MD
Novatek Pharmaceuticals

Active, not recruiting

NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

Neuroendocrine Carcinoma | Gastroenteropancreatic Neuroendocrine Tumor | Gastroenteropancreatic Neuroendocrine Neoplasm | Mixed Neuroendocrine-Non Neuroendocrine Neoplasm

United States
NC Heart and Vascular Research, LLC
Novate Medical Limited, a BTG Group Company

Completed

A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up

Recurrent Pulmonary Embolism (Disorder)

United States

Clinical Trials Sponsored by Novastep

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations